Rose Collard

Dr. Rose Collard


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
RCRose Collard
Rose Collard
HCHannie C. Comijs
Hannie C. Comijs
PNPaul Naarding
Paul Naarding
BPBrenda W. Penninx
Brenda W. Penninx
YMYuri Milaneschi
Yuri Milaneschi
RVRichard Christiaan Oude Voshaar
Richard Christiaan Oude Voshaar

1 June 2017 in European Psychiatry
Verified
Journal Article
Closed access
RCRose Collard
Rose Collard
MAM.H.L. Arts
M.H.L. Arts
ASA.H. Schene
A.H. Schene
PNP. Naarding
P. Naarding
RVRichard Christiaan Oude Voshaar
Richard Christiaan Oude Voshaar
HCH.C. Comijs
H.C. Comijs
Background: Physical frailty and depressive symptoms are reciprocally related in community-based studies, but its prognostic impact on depressive disorder remains unknown.Methods: A cohort of 378 older persons (≥ 60 years) suffering from a depressive disorder (DSM-IV criteria) was reassessed at two-year follow-up. Depressive symptom severity was assessed every six months with the Inventory of Depressive Symptomatology, including a mood, motivational, and somatic subscale. Frailty was assessed according to the physical frailty phenotype at the baseline examination.Results: For each additional frailty component, the odds of non-remission was 1.24 [95% CI = 1.01–1.52] (P= 040). Linear mixed models showed that only improvement of the motivational (P< 001) subscale and the somatic subscale (P= 003) of the IDS over time were dependent on the frailty severity.Conclusions: Physical frailty negatively impacts the course of late-life depression. Since only improvement of mood symptoms was independent of frailty severity, one may hypothesize that frailty and residual depression are easily mixed-up in psychiatric treatment.

9 March 2023 in Journal of Psychiatric Research
Verified
Journal Article
Open access
JKJ.D. Kist
J.D. Kist
JVJ.N. Vrijsen
J.N. Vrijsen
PMP.C.R. Mulders
P.C.R. Mulders
PEPhilip Van Eijndhoven
Philip Van Eijndhoven
ITI. Tendolkar
I. Tendolkar
RCRose Collard
Rose Collard
Heterogeneity and comorbidity in psychiatric disorders are common, however, little is known about the impact on well-being and the role of functional limitations. We aimed to identify transdiagnostic psychiatric symptom profiles and to study their association with well-being and the mediating role of functional limitations in a naturalistic psychiatric patient group. We used four disorder-specific questionnaires to assess symptom severity within a sample of 448 psychiatric patients with stress-related and/or neurodevelopmental disorders and 101 healthy controls. Using both exploratory and confirmatory factor analyses we identified transdiagnostic symptom profiles, which we entered into a linear regression analysis to assess their association with well-being and the mediating role of functional limitations in this association. We identified eight transdiagnostic symptom profiles, covering mood, self-image, anxiety, agitation, empathy, non-social interest, hyperactivity and cognitive focus. Mood and self-image showed the strongest association with well-being in both patients and controls, while self-image also showed the highest transdiagnostic value. Functional limitations were significantly associated with well-being and fully mediated the relationship between cognitive focus and well-being. The participant sample consisted of a naturalistic group of out-patients. While this strengthens the ecological validity and transdiagnostic perspective of this study, the patients with a single neurodevelopmental disorder were underrepresented. Transdiagnostic symptom profiles are valuable in understanding what reduces well-being in psychiatric populations, thereby opening new avenues for functionally meaningful interventions.

1 October 2019 in European Psychiatry
Verified
Journal Article
Open access
SWSanne Wassink-Vossen
Sanne Wassink-Vossen
RCRose Collard
Rose Collard
KWKlaas J. Wardenaar
Klaas J. Wardenaar
PVPeter F.M. Verhaak
Peter F.M. Verhaak
DRDidi Rhebergen
Didi Rhebergen
RVRichard Christiaan Oude Voshaar
Richard Christiaan Oude Voshaar
Background: In mental health research, functional recovery is increasingly valued as an important outcome in addition to symptomatic remission.Methods: Course types of functional limitations among depressed older patients and its relation with symptomatic remission were explored in a naturalistic cohort study (Netherlands Study of Depression in Older persons). 378 depressed older patients (≥60 years) and 132 non-depressed persons were included. Depressive disorders were assessed with Composite International Diagnostic Interview at baseline and two-year follow-up. Functional limitations were assessed every 6 months with the World Health Organization Disability Assessment II.Results: Depressed patients had more functional limitations compared to their non-depressed counterparts. Growth Mixture Modeling among depressed patients identified two trajectories of functional limitations, both starting at a high disability level. The largest subgroup (81.2%) was characterized by a course of high disability levels over time. The smaller subgroup (18.8%) had an improving course (functional recovery). After two years, the main predictor of functional recovery was the remission of depression. Among symptomatic remitted patients, female sex, higher level of education, higher gait speed, and less severe depression were associated with no functional recovery. Non-remitted patients without functional recovery were characterized by the presence of more chronic somatic diseases, a lower sense of mastery, and a higher level of anxiety.Conclusions: 1 in 5 depressed older patients have a course with functional recovery. Combining functional and symptomatic recovery points to a subgroup of older patients that might profit from more rigorous psychiatric treatment targeted at psychiatric comorbidity and a group of frail depressed older patients that might profit from integrated geriatric rehabilitation.

29 March 2022 in JMIRx Med
Verified
Journal Article
Open access
PEPhilip Van Eijndhoven
Philip Van Eijndhoven
RCRose Collard
Rose Collard
JVJanna Vrijsen
Janna Vrijsen
DGDirk E M Geurts
Dirk E M Geurts
AVAlejandro Arias Vasquez
Alejandro Arias Vasquez
ASAart Schene
Aart Schene
Background: It is widely acknowledged that comorbidity between psychiatric disorders is common. Shared and diverse underpinnings of psychiatric disorders cannot be systematically understood based on symptom-based categories of mental disorders, which map poorly onto pathophysiological mechanisms. In the Measuring Integrated Novel Dimensions in Neurodevelopmental and Stress-Related Mental Disorders (MIND-SET) study, we make use of current concepts of comorbidity that transcend the current diagnostic categories. We test this approach to psychiatric problems in patients with frequently occurring psychiatric disorders and their comorbidities (excluding psychosis). Objective: The main aim of the MIND-SET project is to determine the shared and specific mechanisms of neurodevelopmental and stress-related psychiatric disorders at different observational levels. Methods: This is an observational cross-sectional study. Data from different observational levels as defined in the Research Domain Criteria (genetics, physiology, neuropsychology, system-level neuroimaging, behavior, self-report, and experimental neurocognitive paradigms) are collected over four time points. Included are adult (aged ≥18 years), nonpsychotic, psychiatric patients with a clinical diagnosis of a stress-related disorder (mood disorder, anxiety disorder, or substance use disorder) or a neurodevelopmental disorder (autism spectrum disorder or attention-deficit/hyperactivity disorder). Individuals with no current or past psychiatric diagnosis are included as neurotypical controls. Data collection started in June 2016 with the aim to include a total of 650 patients and 150 neurotypical controls by 2021. The data collection procedure includes online questionnaires and three subsequent sessions with (1) standardized clinical examination, physical examination, and blood sampling; (2) psychological constructs, neuropsychological tests, and biological marker sampling; and (3) neuroimaging measures. Results: We aim to include a total of 650 patients and 150 neurotypical control participants in the time period between 2016 and 2022. In October 2021, we are at 95% of our target. Conclusions: The MIND-SET study enables us to investigate the mechanistic underpinnings of nonpsychotic psychiatric disorders transdiagnostically. We will identify both shared and disorder-specific markers at different observational levels that can be used as targets for future diagnostic and treatment approaches.

1 January 2015 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
RCRose Collard
Rose Collard
MAMatheus Arts
Matheus Arts
HCHannie C. Comijs
Hannie C. Comijs
PNPaul Naarding
Paul Naarding
PVPeter F.M. Verhaak
Peter F.M. Verhaak
RVRichard Christiaan Oude Voshaar
Richard Christiaan Oude Voshaar